Maternal depression and child behavioural outcomes - The Lancet

3 downloads 0 Views 84KB Size Report
Oct 10, 2014 - who are not pregnant.2 Postpartum depression affects ... Hannelie Coetzee/Great Stock/Corbis ... Sainte-Justine, Montreal, QC, Canada.
Comment

3

4

5

6

Stepniak B, Papiol S, Hammer C, et al. Accumulated environmental risk determining age at schizophrenia onset: a deep phenotyping-based study. Lancet Psychiatry 2014; published online Oct 22. http://dx.doi. org/10.1016/S2215-0366(14)70379-7. Verdoux H, Geddes JR, Takei N, Lawrie SM, Bovet P, Eagles JM, et al. Obstetric complications and age at onset in schizophrenia: an international collaborative meta-analysis of individual patient data. Am J Psychiatry 1997; 154: 1220–27. Large M, Sharma S, Compton MT, Slade T, Nielssen O. Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Arch Gen Psychiatry 2011; 68: 555–61. Eranti SV, MacCabe JH, Bundy H, Murray RM. Gender difference in age at onset of schizophrenia: a meta-analysis. Psychol Med 2013; 43: 155–67.

7

8 9

10

Esterberg ML, Trotman HD, Holtzman C, Compton MT, Walker EF. The impact of a family history of psychosis on age-at-onset and positive and negative symptoms of schizophrenia: a meta-analysis. Schizophr Res 2010; 120: 121–30. Fromer M, Pocklington AJ, Kavanagh DH, et al. De novo mutations in schizophrenia implicate synaptic networks. Nature 2014; 506: 179–84. Ripke S, O’Dushlaine C, Chambert K, et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet 2013; 45: 1150–59. Lawrie SM, Olabi B, Hall J, McIntosh AM. Do we have any solid evidence of clinical utility about the pathophysiology of schizophrenia? World Psychiatry 2011; 10: 19–31.

Hannelie Coetzee/Great Stock/Corbis

Maternal depression and child behavioural outcomes

Published Online October 10, 2014 http://dx.doi.org/10.1016/ S2215-0366(14)70375-X See Articles page 454

408

Depression is a leading cause of disability worldwide,1 with higher prevalence in women than in men. The postpartum period might confer additional risk to women; rates of major depressive disorder are raised slightly in the postnatal period relative to women who are not pregnant.2 Postpartum depression affects about 15% of women.3 Little is known about maternal depression in countries of low and middle income, although in a review of 47 studies spanning pregnancy and the postnatal period, common maternal mental health disorders (including depression) were noted in 19·8% of women.4 These findings are worrying because, globally, many children will be exposed to maternal depression, and maternal depression is generally regarded as a robust risk factor with wide-reaching effects on children’s emotional, behavioural, cognitive, physical, and neural development.5,6 Empirical information on the long-term association between maternal depression and child outcome in countries of low and middle income is scarce.7 Children in these settings are potentially at even greater risk from the negative effects of maternal depression, beginning very early in life. Strong associations exist between maternal depression and infant undernutrition, low birthweight, and psychosocial risk, possibly compounded by in-utero adversity because of famine or natural disasters.7,8 In The Lancet Psychiatry, Nienke Verkuijl and colleagues report a longitudinal study in South Africa to investigate the association between symptoms of postnatal maternal depression and children’s psychological development at age 10 years.9 Children whose mothers had symptoms of depression at 6 months postpartum were more than twice as likely as children whose mothers did not have postnatal

depression to have psychological problems at age 10 years, controlling for socioeconomic status and current maternal depression (adjusted odds ratio 2·26, 95% CI 1·23–4·16). These longitudinal associations pertained most specifically to children scoring in the upper 10th percentile for externalising problems at age 10 years (1·71, 0·95–3·10). Longitudinal links between postnatal depression and children’s internalising difficulties disappeared once current maternal depression was taken into account (1·38, 0·77–2·48). To my knowledge, this study is one of only a few done in countries of low and middle income to include a longterm behavioural follow-up of children whose mothers have elevated depressive symptoms. However, the study by Verkuijl and colleagues is not without its limitations. At the best of times, retaining participants in a longitudinal study for more than a decade, particularly vulnerable individuals, is a challenge. Attrition is possibly more pronounced in countries of low and middle income than in highincome settings because the research infrastructure might be less developed; moreover, sociocultural factors could affect attrition—eg, no permanent home. Attrition was one of the main limitations of the study by Verkuijl and colleagues.9 3273 women were enrolled when mother-child dyads were recruited, yet 10-year follow-up data were available for only 644 dyads, translating to a retention rate of about 20% of the original sample. The authors acknowledged this limitation and noted that it could be attributable partly to patterns of circular urban-rural temporary migration. Furthermore, different measures were used to assess maternal depression, with the Pitt depression inventory administered in the early postnatal period (6 months www.thelancet.com/psychiatry Vol 1 November 2014

Comment

after birth) and the Center for Epidemiologic Studies depression scale (CES-D) used at 10-year follow-up. Correlations between these two timepoints were low, although about 20% of women scored above the cutoff at both 6 months and 10 years. No measures of maternal depression or children’s psychological difficulties were recorded between these two timepoints, which is unfortunate in view of the links between postnatal depression and child psychological outcome. We are left with a snapshot of maternal depression 6 months after birth and at 10-year follow-up, but without information throughout the child’s life, which could help us to better understand the underlying mechanisms in the intergenerational transfer of risk. Therefore, drawing a conclusion about whether the postpartum period confers a specific risk for child psychological functioning is difficult, without understanding more about the chronicity and severity of depression over time, factors that have been shown to affect child outcome in studies set in high-income countries.10 Despite these methodological shortcomings, findings of studies in countries of low and middle income must reach the public and receive the attention they deserve. Since we know that maternal depression is a robust risk factor for poor child outcome, and that associations can be striking in low-income and middle-income settings because of biological (eg, the effects of undernutrition) and psychosocial stressors, Verkuijl and colleagues’ findings could represent a conservative estimate of the problem. Research studies on maternal mental health in countries of low and middle income will raise awareness of issues faced by women and the negative effects for the child;

furthermore, they could indicate to whom and how best to target interventions in an attempt to reduce the intergenerational transfer of risk. Catherine M Herba Department of Psychology, Université du Québec à Montréal, Montreal, QC, Canada H2X 3P2; and Centre de Recherche du CHU Sainte-Justine, Montreal, QC, Canada [email protected] I declare no competing interests. Copyright © Herba. Open Access article distributed under the terms of CC BY-NC-ND. 1 2

3

4

5

6

7

8

9

10

Murray CJ, Lopez AD. Measuring the global burden of disease. N Engl J Med 2013; 369: 448–57. Vesga-Lopez O, Blanco C, Keyes K, Olfson M, Grant BF, Hasin DS. Psychiatric disorders in pregnant and postpartum women in the United States. Arch Gen Psychiatry 2008; 65: 805–15. Marcus SM. Depression during pregnancy: rates, risks and consequences—Motherisk Update 2008. Can J Clin Pharmacol 2009; 16: e15–22. Fisher J, Cabral de Mello M, Patel V, et al. Prevalence and determinants of common perinatal mental disorders in women in low- and lower-middle-income countries: a systematic review. Bull World Health Organ 2012; 90: 139G–49G. Weissman MM, Wickramaratne P, Nomura Y, Warner V, Pilowsky D, Verdeli H. Offspring of depressed parents: 20 years later. Am J Psychiatry 2006; 163: 1001–08. Lupien SJ, Parent S, Evans AC, et al. Larger amygdala but no change in hippocampal volume in 10-year-old children exposed to maternal depressive symptomatology since birth. Proc Natl Acad Sci USA 2011; 108: 14324–29. Rahman A, Surkan PJ, Cayetano CE, Rwagatare P, Dickson KE. Grand challenges: integrating maternal mental health into maternal and child health programmes. PLoS Med 2013; 10: e1001442. Monk C, Spicer J, Champagne FA. Linking prenatal maternal adversity to developmental outcomes in infants: the role of epigenetic pathways. Dev Psychopathol 2012; 24: 1361–76. Verkuijl NE, Richter L, Norris SA, Stein A, Avan B, Ramchandani PG. Postnatal depressive symptoms and child psychological development at 10 years: a prospective study of longitudinal data from the South African Birth to Twenty cohort. Lancet Psychiatry 2014; published online Oct 10. http://dx.doi.org/S2215-0366(14)70361-X. Brennan PA, Hammen C, Andersen MJ, Bor W, Najman JM, Williams GM. Chronicity, severity, and timing of maternal depressive symptoms: relationships with child outcomes at age 5. Dev Psychol 2000; 36: 759–66.

Alternatives to psychiatric diagnosis Discussions about alternatives to psychiatric diagnosis inevitably arouse controversy. But it is difficult to see how things can continue as they are, in view of the seemingly intractable problems facing diagnostic systems. These problems, which have been extensively discussed in relation to the Diagnostic and Statistical Manual of Mental Disorders 5, include the continuing and acknowledged1 failure to find biomarkers, which might validate categories; extensive overlap across www.thelancet.com/psychiatry Vol 1 November 2014

categories and variation of symptoms within them;2–4 and the absence of treatment specificity5 so that, for example, neuroleptics have been recommended for schizophrenia, depression, anxiety, bipolar disorder, personality disorder, and attention deficit hyperactivity disorder.6 Perhaps most worryingly, although some service users experience diagnosis as a relief, a substantial number of other users testify that it conveys messages of deficit and despair, and say that

Published Online October 2, 2014 http://dx.doi.org/10.1016/ S2215-0366(14)70359-1

409